- Home
- PLUR vs FBIO Comparison
PLUR vs FBIO Comparison
Compare PLUR & FBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLUR
- FBIO
- Stock Information
- Founded
- PLUR 2001
- FBIO 2006
- Country
- PLUR Israel
- FBIO United States
- Employees
- PLUR N/A
- FBIO N/A
- Industry
- PLUR Biotechnology: Biological Products (No Diagnostic Substances)
- FBIO Biotechnology: Pharmaceutical Preparations
- Sector
- PLUR Health Care
- FBIO Health Care
- Exchange
- PLUR Nasdaq
- FBIO Nasdaq
- Market Cap
- PLUR 41.9M
- FBIO 49.1M
- IPO Year
- PLUR N/A
- FBIO N/A
- Fundamental
- Price
- PLUR $4.50
- FBIO $1.78
- Analyst Decision
- PLUR
- FBIO Strong Buy
- Analyst Count
- PLUR 0
- FBIO 3
- Target Price
- PLUR N/A
- FBIO $21.00
- AVG Volume (30 Days)
- PLUR 18.1K
- FBIO 158.7K
- Earning Date
- PLUR 05-13-2025
- FBIO 05-15-2025
- Dividend Yield
- PLUR N/A
- FBIO N/A
- EPS Growth
- PLUR N/A
- FBIO N/A
- EPS
- PLUR N/A
- FBIO N/A
- Revenue
- PLUR $1,034,000.00
- FBIO $57,784,000.00
- Revenue This Year
- PLUR $472.39
- FBIO $63.20
- Revenue Next Year
- PLUR $254.29
- FBIO $66.70
- P/E Ratio
- PLUR N/A
- FBIO N/A
- Revenue Growth
- PLUR 203.23
- FBIO N/A
- 52 Week Low
- PLUR $3.33
- FBIO $1.33
- 52 Week High
- PLUR $7.13
- FBIO $2.89
- Technical
- Relative Strength Index (RSI)
- PLUR 44.62
- FBIO 56.56
- Support Level
- PLUR $4.60
- FBIO $1.66
- Resistance Level
- PLUR $5.30
- FBIO $1.84
- Average True Range (ATR)
- PLUR 0.40
- FBIO 0.12
- MACD
- PLUR -0.10
- FBIO -0.00
- Stochastic Oscillator
- PLUR 20.40
- FBIO 75.00
About PLUR Pluri Inc.
Pluri Inc is a biotechnology company, that creates cell-based products for commercial use and is pioneering a biotech revolution that promotes wellbeing and sustainability. The company's technology platform developed a three-dimensional, or 3D, technology platform for cell expansion with an industrial scale in-house Good Manufacturing Practice, or GMP, cell manufacturing facility. It uses its technology in the field of regenerative medicine, food tech and agricultural technology or agtech.
About FBIO Fortress Biotech Inc.
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology and therapeutics sectors.